SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 2.502
AS - Asia 2.323
EU - Europa 901
SA - Sud America 367
AF - Africa 225
OC - Oceania 27
AN - Antartide 1
Totale 6.346
Nazione #
US - Stati Uniti d'America 2.344
SG - Singapore 855
CN - Cina 441
IT - Italia 277
BR - Brasile 229
HK - Hong Kong 200
DE - Germania 147
ID - Indonesia 139
EG - Egitto 134
GB - Regno Unito 131
VN - Vietnam 124
IN - India 102
MX - Messico 85
IQ - Iraq 76
TR - Turchia 64
CA - Canada 62
JP - Giappone 57
FI - Finlandia 46
RU - Federazione Russa 46
EC - Ecuador 43
IR - Iran 41
FR - Francia 40
PL - Polonia 36
PH - Filippine 35
NL - Olanda 34
PK - Pakistan 34
ZA - Sudafrica 29
AU - Australia 27
AR - Argentina 25
TW - Taiwan 24
AT - Austria 22
BD - Bangladesh 22
KR - Corea 22
PE - Perù 22
SA - Arabia Saudita 22
UA - Ucraina 22
ES - Italia 19
MY - Malesia 17
SE - Svezia 14
CO - Colombia 13
KE - Kenya 12
NG - Nigeria 12
BO - Bolivia 11
CL - Cile 11
CZ - Repubblica Ceca 11
BE - Belgio 9
DZ - Algeria 9
MA - Marocco 9
VE - Venezuela 9
CH - Svizzera 8
RO - Romania 8
PS - Palestinian Territory 7
HU - Ungheria 6
JO - Giordania 5
LT - Lituania 5
GR - Grecia 4
HN - Honduras 4
IE - Irlanda 4
IL - Israele 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
LB - Libano 3
LY - Libia 3
MM - Myanmar 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
BF - Burkina Faso 2
ET - Etiopia 2
KG - Kirghizistan 2
LS - Lesotho 2
LV - Lettonia 2
MG - Madagascar 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AQ - Antartide 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 6.346
Città #
Singapore 481
Dallas 340
Ashburn 324
Santa Clara 220
Hong Kong 180
Beijing 176
Fairfield 108
Chandler 102
Los Angeles 85
Jakarta 76
Woodbridge 65
Alexandria 52
Ho Chi Minh City 49
Houston 49
Seattle 44
Wilmington 40
Cambridge 37
Cairo 35
Ferrara 35
Mexico City 34
Munich 34
Ann Arbor 33
New York 32
Shanghai 32
Tokyo 32
Warsaw 31
Baghdad 30
Hanoi 29
São Paulo 29
London 28
Princeton 28
Montreal 26
Hefei 24
Helsinki 24
Atlanta 23
Chicago 23
Frankfurt am Main 20
Bologna 19
Buffalo 19
Brooklyn 18
Izmir 18
Jacksonville 18
Nanjing 17
Poplar 17
Denver 16
Falkenstein 16
Quito 16
Toronto 16
Milan 15
Ankara 14
Boston 14
Johannesburg 14
Lappeenranta 14
Manchester 14
Najaf 14
San Diego 14
Lima 13
Nuremberg 13
Orem 13
Padova 13
Phoenix 13
Sydney 13
Athens 12
Chennai 11
Miami 11
Rome 11
City of London 10
Council Bluffs 10
Guayaquil 10
Hillah 10
Stockholm 10
Vienna 10
Delhi 9
Lahore 9
Medan 9
Moscow 9
Nairobi 9
Naples 9
Secaucus 9
Tainan City 9
Tanta 9
Brussels 8
Kuala Lumpur 8
Melbourne 8
Milwaukee 8
Mumbai 8
Rio de Janeiro 8
Surabaya 8
Addison 7
Bengaluru 7
Boardman 7
Edinburgh 7
Manila 7
Mérida 7
New Delhi 7
Osaka 7
Riyadh 7
Taipei 7
Amsterdam 6
Assago 6
Totale 3.715
Nome #
Systemic lupus erythematosus: one year in review 2023 798
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 305
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 247
Novel insights into the management of rheumatoid arthritis: one year in review 2022 232
Novel insights into the management of rheumatoid arthritis: one year in review 2023 211
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 176
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 157
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 155
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 153
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 140
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 133
Biological and synthetic target DMARDs in psoriatic arthritis 129
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 126
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 125
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 124
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 118
One year in review 2018: novelties in the treatment of rheumatoid arthritis 118
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 116
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 115
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 112
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 111
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 111
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 108
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 104
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 104
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 102
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 98
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 98
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 96
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 93
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 90
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 86
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 84
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 81
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 80
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 79
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 77
Systemic lupus erythematosus: one year in review 2024 75
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 75
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 72
One year in review 2019: novelties in the treatment of rheumatoid arthritis 71
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 69
One year in review 2021: novelties in the treatment of rheumatoid arthritis 67
Neurologic Involvement in Rheumatic Diseases 62
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 60
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 60
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 59
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 56
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 55
One year in review 2020: novelties in the treatment of rheumatoid arthritis 52
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 48
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 47
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 47
Systemic lupus erythematosus: one year in review 2025 44
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 42
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 25
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 19
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 17
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 10
Role of Musculoskeletal Ultrasound in Diagnosing and Managing Chronic Inflammatory Arthritis in Overweight and Obese Patients: a narrative review. 3
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 2
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 1
Totale 6.530
Categoria #
all - tutte 33.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 193
Totale 33.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 11 11 17 13 23 17 9
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20262.779 431 210 622 498 784 234 0 0 0 0 0 0
Totale 6.530